Kristen Coppock, MA

Common factors that contributed to increased dissatisfaction at work included workflow disruptions, role conflict, quantity of work, organizational culture, and leadership support.

Other HPV-associated cancers were found to have increased over the study period, linking this trend to lack of guidelines and other resources.

Patient and provider organizations urge the Department of Health and Human Services and the Biden administration to enact policies and protections that improve prescription drug affordability for people in the United States.

The Prevention on the Go program has detected more than 50 cases of cancer over a 4-year period.

Trials confirm patients with chronic lymphocytic leukemia treated with venetoclax-based regimens achieve higher rates of undetectable minimal residual disease, which may be associated with a lower risk of future disease progression or death.

Grief can affect an organization as well as an individual; however, there are management strategies that can be used for addressing these issues.

Gilead Sciences' remdesivir is the first drug to receive FDA approval for treating COVID-19 in the United States.

As pharmacy practice evolves and the role of pharmacists continues to expand, the notion of working alongside other health care professionals to provide patient services is becoming more widely accepted as key to a pharmacist’s job.

Individuals may use a significant number of OTC products during cold and flu season.

PBMs currently operate in Arkansas with no government oversight

Nearly all states are experiencing a high burden from the flu, according to the CDC.

The CDC and the American Academy of Pediatrics released an updated vaccination schedule.

Study results show patients with newly diagnosed multiple myeloma showed a lower risk of disease progression or death with daratumumab added to the standard regimen of bortezomib, melphalan and prednisone, than patients who were treated without daratumumab in their drug combination.

The updated 2018 immunization schedules for children and teens has been released by the Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) and the American Academy of Pediatrics (AAP).